Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas

Michael Weaver, Douglas W. Laske(Temple University)

Journal of Neuro-Oncology

October 1, 2003

10.1023/a:1026246500788

Cited by 300

Abstract

Related Papers

Transferrin receptor on endothelium of brain capillaries

Wilfred A. Jefferies, Malcolm R. Brandon, Simon V. Hunt et al.|Nature|1984|1.1k

Receptor-mediated endocytosis of transferrin in K562 cells.

Richard D. Klausner, Jos van Renswoude, Gilbert Ashwell et al.|Journal of Biological Chemistry|1983|571

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

Douglas W. Laske, Richard J. Youle, Edward H. Oldfield|Nature Medicine|1997|530

Modulation of cell surface iron transferrin receptors by cellular density and state of activation

James W. Larrick, Peter Cresswell|Journal of Supramolecular Structure|1979|361

TRANSFERRIN AND TRANSFERRIN RECEPTORS IN CARCINOMA OF THE BREAST

W. Pagé Faulk, Bae‐Li Hsi, P.J. Stevens|The Lancet|1980|279